Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey

Journal of Forensic and Legal Medicine

Volumn 20, Issue 6, 2013, Pages 667-672

  Gurdal, Fatma ^a   Asirdizer, Mahmut ^b   Aker, Rezzan Gulhan ^a,c   Korkut, Senol ^a   Gocer, Yasemin ^c   Kucukibrahimoglu, E Esra ^c   Ince, C Haluk ^a  

^a Istanbul Chemistry Department Narcotic Division ^*  (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

^c MARMARA UNIVERSITY   (Turkey)

Author keywords

Frequency; Herbal highs; Legal highs; New designer drugs; Synthetic cannabinoids; Types

Indexed keywords

3 (1 NAPHTHOYL) 1 PENTYLINDOLE; 4' METHYLMETHCATHINONE; CANNABINOID DERIVATIVE; CATHINONE; DESIGNER DRUG; HERBACEOUS AGENT; ICOSANOID; NORPSEUDOEPHEDRINE; PYRAZOLE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; DRUG DETERMINATION; FORENSIC MEDICINE; TURKEY (REPUBLIC);

FREQUENCY; HERBAL HIGHS; LEGAL HIGHS; NEW DESIGNER DRUGS; SYNTHETIC CANNABINOIDS; TYPES;

ALKALOIDS; CANNABINOIDS; DESIGNER DRUGS; FORENSIC TOXICOLOGY; HUMANS; INDOLES; METHAMPHETAMINE; NAPHTHALENES; PHENYLPROPANOLAMINE; PLANT PREPARATIONS; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; TURKEY;

EID: 84885020980     PISSN: 1752928X     EISSN: 18787487     Source Type: Journal    
DOI: 10.1016/j.jflm.2013.03.041     Document Type: Article

References (34)

1. Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 2001 Feb;178(2):101-6. (Pubitemid 32158071)
2. Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006 Sep;58(3):389-462. (Pubitemid 44394908)
3. Ottani A, Giuliani D. HU 210: a potent tool for investigations of the cannabinoid system. CNS Drug Rev 2001 Summer;7(2):131-45. (Pubitemid 32656298)
4. Abel EL. Marihuana: the first twelve thousand years. Available: http://druglibrary.org/schaffer/hemp/history/first12000/abel.htm [accessed 04.03.13].
5. Hall W, Solowij N, Lemon J. The health and psychological consequences of cannabis use - National Drug Strategy monograph series no. 25. Available: http://www.health.gov.au/internet/main/publishing.nsf/Content/ health-pubs-drug-cannab2-ch8.htm [accessed 04.03.13].
6. Lemberger L. Potential therapeutic usefulness of marijuana. Ann Rev Pharmacol Toxicol 1980;20:151-72.
7. Adams R, Harfenist M, Loewe S. New analogs of tetrahidrocannabinol-XIX. J Am Chem Soc 1949;71(5):1624-8.
8. Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964;86(8):1646-7.
9. EMCDDA. Understanding the 'Spice' phenomenon. Available: http://www.emcdda.europa.eu/attachements.cfm/att-80086-EN- Spice%20Thematic%20paper%20%E2%80%94%20 final%20version.pdf [accessed 04.03.13].
10. Vardakou I, Pistos C, Spiliopoulou CH. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett 2010;197(3):157-62.
11. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, et al. International Union of pharmacology; XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002;54(2):161-202. (Pubitemid 34575709)
12. UNODC. Synthetic cannabinoids in herbal products. Available: http://www.google.com.tr/ url%3fsa%3dt% 26rct%3dj%26q%3dsynthetic%20cannabinoids%20in%20herbal%20products% 26source%3dweb%26cd%3d2%26sqi%3d2%26ved%3d0CFkQFjAB%26url%3dhttp%3A%2F%2Fwww. unodc.org%2Fdocuments%2Fscientific%2FSynthetic-Cannabinoids. pdf%26ei%3dFOO7T8SqLKPe4QTAvvWnCQ%26usg%3dAFQjCNHfl9CuZIWWx-jbSaS8jR4v1lrmYQ [accessed 04.03.13].
13. ACMD. ACMD report on the major cannabinoid agonist: consideration of major cannabinoid agonist. Available: http://www.drugsandalcohol.ie/13907/1/ Home-office-acmd-report-cannabinoid-agonists.pdf [accessed 04.03.13].
14. Zuba D, Byrska B, Maciow M. Comparison of "herbal highs" composition. Anal Bioanal Chem 2011 Apr;400(1):119-26.
15. Lindigkeit R, Boehme A, Eiserloh I, Luebbecke M, Wiggermann M, Ernst L, et al. Spice: a never ending story? Forensic Sci Int 2009 Oct 30;191(1-3):58-63.
16. Seely KA, Lapoint J, Moran JH, Fattore L. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 2012 Dec 3;39(2):234-43.
17. Pierre JM. Cannabis, synthetic cannabinoids, and psychosis risk: what the evidence says. Curr Psychiatr 2011 Sep;10(9):49-58.
18. Fattore L, Fratta W, Beyond THC. The new generation of cannabinoid designer drugs. Front Behav Neurosci 2011 Sep;5(60):1-12.
19. Army Center for Substance Abuse Programs. Spice: herbal incense awareness. Available: http://redcloud.korea.army.mil/ASAP-Helpful-Resources/ Downloads/Spice.pdf [accessed 04.03.13].
20. The Psychonaut Web Mapping Research Group. Spice report. London UK: Institute of Psychiatry, King's Collage London; 2009.
21. Piggee C. Investigating a not-so-natural high: researchers identify synthetic cannabinoids in herbal incense. Anal Chem 2009 May;81(9):3205-7.
22. Rannazzisi JT. Senate Caucus on International Narcotics Control United States Senate, "The Dangers of synthetic cannabinoids and Stimulants". Available: http://www.justice.gov/dea/pr/speeches-testimony/2012-2009/110412- testimony.pdf [accessed 04.03.13].
23. Maryland Department of Legislative Services. Fiscal and policy note: public charter schools located on a military base. Available: http://mgaleg.maryland.gov/2011rs/fnotes/bil-0009/hb0189.pdf [accessed 04.03.13].
24. Executive Office of the President, Fact Sheet Office of National Drug Control Policy. Synthetic marijuana. Available: http://www.whitehouse.gov/sites/ default/files/ondcp/Blog/synthetic-marijuana.pdf [accessed 04.03.13].
25. Akgül A, Asicioglu F. Uyuşturucu maddelerde yeni trendler ve erken uyari sistemi. In: Demir OÖ, Sever M, editors. Örgütlü Suçlar ve Yeni Trendler. Ankara (Turkey): Polis Akademisi Yayinlari; 2011. p. 29-56.
26. Presidenza del Consiglio del Ministri, Dipartimento Politiche Antidroga. Report ATTIVITÀ: Il fenomeno dei cannabinoidi sintetici in Italia e le azioni di contrasto e controllo degli smart shop. Available: http://www.allertadroga.it/sapd/upload/Report-smart-shop-marzo-2011.pdf [accessed 04.03.13].
27. Norchem Newsletter. Drug trends in the criminal justice market. No:001. Available: http://www.norchemlab.com/wp-content/uploads/2011/08/NOR-Newsletter- v6.pdf; March 2012 [accessed 04.03.13].
28. NMS Labs. Designer drug trends report: synthetic cannabinoids in urine. Available: http://www.nmslabs.com/uploads/PDF/Designer%20Drug%20Trends%20Report. pdf [accessed 04.03.13].
29. Health Care Provider Fact Sheet of MDCH Bureau of Disease Control, Prevention & Epidemiology and Children's Hospital of Michigan Poison Control Center. Synthetic marijuana (synthetic cannabinoid homologues). Available: http://www.childrensdmc.org/upload/docs/Drug%20Abuse/03-19-12%20Updated- Synthetic%20Marijuana-HCPFactSheet.pdf [accessed 04.03.13].
30. Gattardo R, Tagliaro F. I cannabinoidi sintetici, una nuova classe di sostanze d'abuso: Problemi e prospettive analitiche. Italian J Addict 2011;1(5-6):17-22.
31. Hudson S, Ramsey J, King L, Timbers S, Maynard S, Dargan PI, et al. Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. J Anal Toxicol 2010 Jun;34(5):252-60.
32. Asicioglu F. New psycho-active substances: the legal procedure used in European Union Countries and Turkey. Bull Clin Psychopharmacol 2010;20(4):334-9.
33. Republic of Turkey, Ministry of Interior, Turkish National Police, Anti-Smuggling and Organized Crime Department. National report (2010 data) to the EMCDDA by the Reitox National Focal Point: "Turkey " new development, trends and in-depth information on selected issues. Available: http://www.kom.gov.tr/Tr/Dosyalar/file/TUBIM-RAPOR/ TURKISH%20DRUG%20REPORT%202011.pdf; 2011 [accessed 04.03.13].
34. Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow...and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 2012 Mar;8(1):15-32.